RERHYZEN
Live / Registered — Registered (as of 17 Jan 2023)
What this means for you
Registered since 17 Jan 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97235553
- Registration number
- 6957296
- Mark type
- Stylized text
- Filed
- 24 Jan 2022
- Published for opposition
- 01 Nov 2022
- Registered
- 17 Jan 2023
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Brentford, Middlesex, GB
- Glaxo Group Limited, Brentford, Middlesex, GB
Prosecution history
- 06 Oct 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Oct 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Oct 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Oct 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 06 Oct 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 17 Jan 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Jan 2023 — REGISTERED-PRINCIPAL REGISTER
- 09 Nov 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Nov 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Nov 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Nov 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Nov 2022 — PUBLISHED FOR OPPOSITION
- 12 Oct 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Sept 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Sept 2022 — ASSIGNED TO EXAMINER